Oculogenex
About:
Oculogenex is a biopharmaceutical company that specializes in gene therapy for the treatment of retinal disorders.
Website: https://oculogenex.com
Top Investors: National Science Foundation, MassChallenge
Description:
Oculogenex is a biopharmaceutical company that specializes in gene therapy for the treatment of retinal disorders. The company was founded in 2020 and is headquartered in La Habra, California.
Total Funding Amount:
$1.28M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
La Habra, California, United States
Founded Date:
2020-01-01
Contact Email:
info(AT)oculogenex.com
Founders:
Hema Ramkumar, Ram Ramkumar
Number of Employees:
11-50
Last Funding Date:
2022-05-02
IPO Status:
Private
Industries:
© 2025 bioDAO.ai